Koyfin Home > Directory > Health Care > Kezar Life Sciences Inc > Cash and Short-Term Investments

Kezar Life Sciences Inc Cash and Short-Term Investments Chart (KZR)

Kezar Life Sciences Inc annual/quarterly Cash and Short-Term Investments from 2017 to 2020.
  • Kezar Life Sciences Inc Cash and Short-Term Investments for the quarter ending June 06, 2020 was $157m a 45.87% increase of 72m year over year
  • Kezar Life Sciences Inc Cash and Short-Term Investments for the last 12 months ending June 06, 2020 was $157m a 45.87% increase of 72m year over year
  • Kezar Life Sciences Inc Annual Cash and Short-Term Investments for 2019 was $78m a -37.37% decrease of -29m from 2018
  • Kezar Life Sciences Inc Annual Cash and Short-Term Investments for 2018 was $107m a 52.50% increase of 56m from 2017
  • Kezar Life Sciences Inc Annual Cash and Short-Term Investments for 2017 was $51m a 80.90% increase of 41m from 2016
Other Balance Sheet Metrics:
  • Kezar Life Sciences Inc Total Assets for the quarter ending September 09, 2018 was $120m
  • Kezar Life Sciences Inc Other Liabilities for the quarter ending September 09, 2018 was $3m
  • Kezar Life Sciences Inc Total Equity for the quarter ending September 09, 2018 was $114m a 90.58% increase of 103m year over year
View Chart On Koyfin

Quarterly KZR Cash and Short-Term Investments Data

06/2020$157m
03/2020$123m
12/2019$78m
09/2019$85m
06/2019$93m
03/2019$101m
12/2018$107m
09/2018$113m
06/2018$118m
03/2018$47m

Annual KZR Cash and Short-Term Investments Data

2019$78m
2018$107m
2017$51m
2016$10m